Approval · Notice of Compliance 13292 · 2012
RAMIPRIL: Notice of Compliance 13292
Issued May 25, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13292
- Date
- May 25, 2012
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer and product name change
- Therapeutic class
- Angiotensin Converting Enzyme Inhibitor
- Canadian reference product
- ALTACE